Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nursing Ethical Principles II01:27

Nursing Ethical Principles II

1.3K
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
1.3K
Cancer Survival Analysis01:21

Cancer Survival Analysis

456
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
456
Preclinical Development: Overview01:28

Preclinical Development: Overview

4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

29
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
29
Clinical Trials: Overview01:11

Clinical Trials: Overview

3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Engaging patients throughout the continuum of implementation science and practice: adapted evidence mapping review and practical guide for clinicians and researchers.

Health research policy and systems·2026
Same author

Assessing contribution of effect in oncology combination therapies: lessons learned to inform and optimize future registrational trial designs.

The oncologist·2026
Same author

Analysis of interprofessional education perceptions at the team level: A study across three student cohorts.

Journal of interprofessional education & practice·2026
Same author

Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with Triple Negative Breast Cancer in Both the Early and Metastatic Setting 2025.

Current oncology (Toronto, Ont.)·2026
Same author

Translational evidence for increased central amygdala IL-6 activity in alcohol dependence.

Journal of neuroinflammation·2026
Same author

Engaging patients throughout the continuum of implementation science and practice: adapted evidence mapping review and practical guide for clinicians and researchers.

Health research policy and systems·2026
Same journal

Access Challenges in Allogeneic Hematopoietic Cell Transplant: Identifying At-Risk US States by Exploring Social Vulnerability, Physician Density, and Unmet Need.

JCO oncology practice·2026
Same journal

Getting It Right the First Time: Improving Antibiotic Stewardship in Febrile Oncology Patients Presenting to the Pediatric Emergency Department.

JCO oncology practice·2026
Same journal

Current Roles of Neoadjuvant and Perioperative Immunotherapy in Non-Small Cell Lung Cancer.

JCO oncology practice·2026
Same journal

Impact of Graft-Versus-Host Disease Prophylaxis on Long-Term Outcomes in Patients Surviving Beyond Two Years After Allogeneic Transplantation.

JCO oncology practice·2026
Same journal

Timing Is Not Everything: Reassessing Chrono-Immunotherapy in Clinical Practice.

JCO oncology practice·2026
Same journal

Survival Outcomes in Breast Cancer Patients With Use of Vaginal Estrogen Therapy: A SEER Analysis.

JCO oncology practice·2026
See all related articles

Related Experiment Video

Updated: Sep 13, 2025

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

8.8K

Development of Ambulatory Oncology Clinical Pharmacy Key Performance Indicators Using a Modified Delphi Consensus

Thomas McFarlane1, Rozhannaa Sothilingam1, Olavo Fernandes2

  • 1University of Waterloo, Kitchener, ON, Canada.

JCO Oncology Practice
|July 30, 2025
PubMed
Summary
This summary is machine-generated.

This study developed 14 evidence-based ambulatory oncology clinical pharmacy key performance indicators (AOcpKPIs) through a consensus process. These metrics standardize evaluation and improve patient outcomes in ambulatory oncology pharmacy.

More Related Videos

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

9.0K
Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
07:40

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Published on: March 20, 2021

17.2K

Related Experiment Videos

Last Updated: Sep 13, 2025

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

8.8K
A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

9.0K
Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
07:40

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Published on: March 20, 2021

17.2K

Area of Science:

  • Oncology Pharmacy Practice
  • Health Services Research
  • Quality Improvement

Background:

  • Ambulatory oncology pharmacy practice requires standardized metrics for quality assessment.
  • Existing practices lack a unified approach to evaluating clinical pharmacist activities.

Purpose of the Study:

  • To develop evidence-based ambulatory oncology clinical pharmacy key performance indicators (AOcpKPIs).
  • Establish standardized metrics for evaluating ambulatory oncology pharmacist performance.

Main Methods:

  • A systematic, modified Delphi process involving a panel of oncology pharmacists.
  • Environmental scan of Canadian oncology pharmacy practices and literature review.
  • Three Delphi rounds and a virtual meeting to refine 17 candidate AOcpKPIs.

Main Results:

  • Consensus was reached on 14 ambulatory oncology clinical pharmacy key performance indicators (AOcpKPIs).
  • Key indicators encompass clinical order review, patient education, medication adherence, and drug therapy problem management.
  • The developed AOcpKPIs enable standardized evaluation, benchmarking, and outcome improvement.

Conclusions:

  • The study established a foundational set of quality metrics for ambulatory oncology pharmacy.
  • Consensus-based AOcpKPIs support enhanced patient care, accountability, and continuous quality improvement.
  • Implementation of AOcpKPIs can elevate practice standards and foster evidence-based patient outcomes.